The U.S. Food and Drug Administration delayed regulatory action on an experimental Alzheimers drug that was widely expected to be approved this month, drugmaker Eli Lilly said Friday, citing a need f… [read more]
Related Posts
What to know about Alabama Chief Justice Tom Parker and the embryo ruling – The Washington Post
In the Alabama Supreme Court ruling that said frozen embryos are people, Chief Justice Tom Parker wrote a concurring opinion that sought to define the […]
Cyberattack forces major US health care network to divert ambulances from hospitals – CNN
A major US health care system said Thursday that it is diverting ambulances from several of its hospitals following a cyberattack this week. The cyberattack on […]
2 homicides could be tied to escaped Idaho inmate and accomplice captured after manhunt police say. Here’s what we know – CNN
Police are investigating two homicides that could potentially be linked to an Idaho inmate and his accomplice who allegedly helped him escape from a hospital visit on […]